Altered Glucose Metabolism in Fibroblasts from Patients with Alzheimer's Disease
- 5 September 1985
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 313 (10) , 638-639
- https://doi.org/10.1056/nejm198509053131013
Abstract
To the Editor: Studies over the past decade have made major advances in defining the brain cells that are vulnerable in Alzheimer's disease1 , 2 but not the mechanisms producing cell loss. The major identified risk factor is genetic.3 , 4 Reports of molecular or cellular abnormalities in nonneural tissues, including cultured cells, raise the possibility that other tissues may express genetically determined alterations, which are clinically important only in the brain.5 (A number of inborn errors provide precedents.) Because of reports of abnormalities in glucose utilization in the brain in Alzheimer's disease,6 we compared lactate production and the oxidation of [U-14C]glucose . . .Keywords
This publication has 11 references indexed in Scilit:
- Quantitating the OccultNew England Journal of Medicine, 1985
- Alzheimer’s diseaseNeurochemical Pathology, 1984
- Familial Alzheimer Dementia: a prevalent disorder with specific clinical featuresPsychological Medicine, 1984
- Immunological dysfunction in Alzheimer's diseaseJournal of Neuroimmunology, 1984
- Alzheimer's disease: Genetic aspects and associated clinical disordersAnnals of Neurology, 1983
- Metabolic Processes in Alzheimer's Disease: Adenine Nucleotide Content and Production of 14CO2 from [U‐14C]Glucose In Vitro in Human NeocortexJournal of Neurochemistry, 1983
- Alzheimer's Disease: A Disorder of Cortical Cholinergic InnervationScience, 1983
- Biochemistry of Alzheimer's DementiaJournal of Neurochemistry, 1982
- Insulin stimulation of glucose entry in cultured human fibroblastsJournal of Cellular Physiology, 1979
- ENZYMATIC CYCLINGPublished by Elsevier ,1972